CELIRECO19.: Investigation of the function of innate lymphoid cells (ILC) in the protection of renal complications in COVID-19 patients (Q2867196): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 98.53 percentage) |
(Added qualifier: readability score (P590521): 0.0731508421013604) |
||||||||||||||
| (3 intermediate revisions by 2 users not shown) | |||||||||||||||
| Property / start time | |||||||||||||||
| |||||||||||||||
| Property / start time: 1 April 2020 / rank | |||||||||||||||
| Property / end time | |||||||||||||||
| |||||||||||||||
| Property / end time: 31 December 2020 / rank | |||||||||||||||
| Property / summary: The project presented by LIMM Therapeutics aims to evaluate the possibility of developing NRIL01 (neurnal reprogrammers of innate lymphocytes) in the presence of SARS-CoV-2, thus contributing to minimising renal pathologies as a consequence of infection with this virus. (English) / qualifier | |||||||||||||||
readability score: 0.0731508421013604
| |||||||||||||||
| Property / budget | |||||||||||||||
| |||||||||||||||
| Property / budget: 499,557.0 Euro / rank | |||||||||||||||
| Property / EU contribution | Property / EU contribution | ||||||||||||||
| 492,223.04 Euro
| ||||||||||||||
| Property / contained in Local Administrative Unit | |||||||||||||||
| Property / contained in Local Administrative Unit: União das freguesias de Cantanhede e Pocariça / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / priority axis | |||||||||||||||
| Property / priority axis: Research, Development and Innovation (DIIAS) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / co-financing rate | |||||||||||||||
98.53 percent
| |||||||||||||||
| Property / co-financing rate: 98.53 percent / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / thematic objective | |||||||||||||||
| Property / thematic objective: Research and innovation / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / start time | |||||||||||||||
4 January 2020
| |||||||||||||||
| Property / start time: 4 January 2020 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / end time | |||||||||||||||
28 February 2021
| |||||||||||||||
| Property / end time: 28 February 2021 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
497,090.22 Euro
| |||||||||||||||
| Property / budget: 497,090.22 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / date of last update | |||||||||||||||
23 May 2023
| |||||||||||||||
| Property / date of last update: 23 May 2023 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 13:59, 22 March 2024
Project Q2867196 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CELIRECO19.: Investigation of the function of innate lymphoid cells (ILC) in the protection of renal complications in COVID-19 patients |
Project Q2867196 in Portugal |
Statements
492,223.04 Euro
0 references
497,090.22 Euro
0 references
98.53 percent
0 references
4 January 2020
0 references
28 February 2021
0 references
LIMM THERAPEUTICS, SOCIEDADE ANÓNIMA
0 references
40°21'55.76"N, 8°39'29.95"W
0 references
O projeto apresentado pela LiMM Therapeutics pretende avaliar a possibilidade de desenvolvimento de NRIL01 (reprogramadores neuronais de linfócitos inatos) na presença de SARS-CoV-2, contribuindo desta forma para minimizar as patologias renais como consequência da infeção com este vírus. (Portuguese)
0 references
The project presented by LIMM Therapeutics aims to evaluate the possibility of developing NRIL01 (neurnal reprogrammers of innate lymphocytes) in the presence of SARS-CoV-2, thus contributing to minimising renal pathologies as a consequence of infection with this virus. (English)
7 July 2021
0.0731508421013604
0 references
Le projet présenté par LIMM Therapeutics vise à évaluer la possibilité de développer NRIL01 (reprogrammeurs neuronaux de lymphocytes innés) en présence de SARS-CoV-2, contribuant ainsi à minimiser les pathologies rénales résultant de l’infection par ce virus. (French)
4 December 2021
0 references
Das von LIMM Therapeutics vorgestellte Projekt zielt darauf ab, die Möglichkeit der Entwicklung von NRIL01 (neurale Reprogrammierer von angeborenen Lymphozyten) in Gegenwart von SARS-CoV-2 zu bewerten und so zur Minimierung der Nierenpathologien als Folge einer Infektion mit diesem Virus beizutragen. (German)
13 December 2021
0 references
Het door LIMM Therapeutics gepresenteerde project heeft tot doel de mogelijkheid te evalueren om NRIL01 (neurale herprogrammeurs van aangeboren lymfocyten) te ontwikkelen in aanwezigheid van SARS-CoV-2, en zo bij te dragen aan het minimaliseren van nierpathologieën als gevolg van infectie met dit virus. (Dutch)
18 December 2021
0 references
Il progetto presentato da LIMM Therapeutics mira a valutare la possibilità di sviluppare NRIL01 (riprogrammatori neurali di linfociti innati) in presenza di SARS-CoV-2, contribuendo così a ridurre al minimo le patologie renali come conseguenza dell'infezione da questo virus. (Italian)
17 January 2022
0 references
El proyecto presentado por LIMM Therapeutics pretende evaluar la posibilidad de desarrollar NRIL01 (reprogramadores neurales de linfocitos innatos) en presencia de SARS-CoV-2, contribuyendo así a minimizar las patologías renales como consecuencia de la infección por este virus. (Spanish)
20 January 2022
0 references
LIMM Therapeutics’i esitatud projekti eesmärk on hinnata NRIL01 (kaasasündinud lümfotsüütide ümberprogrammeerijad) tekke võimalust SARS-CoV-2 juuresolekul, aidates seega vähendada selle viirusega nakatumise tagajärjel tekkivaid neerupatoloogiaid. (Estonian)
29 July 2022
0 references
LIMM Therapeutics pristatomu projektu siekiama įvertinti galimybę vystyti NRIL01 (įgimtų limfocitų reprogramatorius) esant SARS-CoV-2, taip prisidedant prie inkstų patologijų, atsiradusių dėl šio viruso infekcijos, sumažinimo. (Lithuanian)
29 July 2022
0 references
Projekt koji je predstavila LIMM terapija ima za cilj procijeniti mogućnost razvoja NRIL01 (neuralnih reprogramera urođenih limfocita) u prisutnosti SARS-CoV-2, čime se doprinosi smanjenju bubrežnih patologija kao posljedica infekcije ovim virusom. (Croatian)
29 July 2022
0 references
Το έργο που παρουσίασε η LIMM Therapeutics έχει ως στόχο να αξιολογήσει την πιθανότητα ανάπτυξης NRIL01 (νεφρικών επαναπρογραμματιστών έμφυτων λεμφοκυττάρων) παρουσίας του SARS-CoV-2, συμβάλλοντας έτσι στην ελαχιστοποίηση των νεφρικών παθολογιών ως συνέπεια της λοίμωξης από αυτόν τον ιό. (Greek)
29 July 2022
0 references
Cieľom projektu, ktorý predstavila LIMM Therapeutics, je zhodnotiť možnosť vzniku NRIL01 (neurálnych preprogramátorov vrodených lymfocytov) za prítomnosti SARS-CoV-2, čím sa prispeje k minimalizácii renálnych patológií v dôsledku infekcie týmto vírusom. (Slovak)
29 July 2022
0 references
LIMM Therapeuticsin esittelemän hankkeen tavoitteena on arvioida mahdollisuutta kehittää NRIL01 (sisäisten lymfosyyttien neurologiset uudelleenohjelmoijat) SARS-CoV-2:n läsnäollessa, mikä auttaa minimoimaan tämän viruksen aiheuttaman infektion aiheuttamia munuaispatologioita. (Finnish)
29 July 2022
0 references
Projekt przedstawiony przez LIMM Therapeutics ma na celu ocenę możliwości rozwoju NRIL01 (nurnalnych przeprogramowań limfocytów wrodzonych) w obecności SARS-CoV-2, przyczyniając się tym samym do zminimalizowania patologii nerek w wyniku zakażenia tym wirusem. (Polish)
29 July 2022
0 references
A LIMM Therapeutics által bemutatott projekt célja, hogy felmérje az NRIL01 (a veleszületett limfociták idegújraprogramozói) kialakulásának lehetőségét SARS-CoV-2 jelenlétében, ezáltal hozzájárulva a vírussal való fertőzöttség következtében fellépő vesebetegségek minimalizálásához. (Hungarian)
29 July 2022
0 references
Cílem projektu předloženého LIMM Therapeutics je vyhodnotit možnost vývoje NRIL01 (neurální reprogramátory vrozených lymfocytů) za přítomnosti SARS-CoV-2, a přispět tak k minimalizaci renálních patologií v důsledku infekce tímto virem. (Czech)
29 July 2022
0 references
LIMM Therapeutics prezentētā projekta mērķis ir izvērtēt iespēju izstrādāt NRIL01 (iedzimtu limfocītu neironu pārprogrammētājus) SARS-CoV-2 klātbūtnē, tādējādi palīdzot mazināt nieru patoloģijas, ko izraisa inficēšanās ar šo vīrusu. (Latvian)
29 July 2022
0 references
Is é is aidhm don tionscadal a chuir Teiripí LIMM i láthair meastóireacht a dhéanamh ar an bhféidearthacht NRIL01 (athchláraitheoirí néaracha limficítí dúchasacha) a fhorbairt i láthair SARS-CoV-2, agus ar an gcaoi sin rannchuidiú le paiteolaíochtaí duánacha a íoslaghdú mar thoradh ar ionfhabhtú an víris sin. (Irish)
29 July 2022
0 references
Namen projekta, ki ga je predstavilo zdravilo LIMM Therapeutics, je oceniti možnost razvoja NRIL01 (neuralni reprogramatorji prirojenih limfocitov) v prisotnosti SARS-CoV-2 in tako prispevati k zmanjšanju ledvičnih patologij, ki so posledica okužbe s tem virusom. (Slovenian)
29 July 2022
0 references
Проектът, представен от LIMM Therapeutics, има за цел да оцени възможността за развитие на NRIL01 (неврални програмисти на вродени лимфоцити) в присъствието на SARS-CoV-2, като по този начин допринася за свеждане до минимум на бъбречните патологии в резултат на инфекция с този вирус. (Bulgarian)
29 July 2022
0 references
Il-proġett ippreżentat mit-Terapewtiċi LIMM għandu l-għan li jevalwa l-possibbiltà li jiġi żviluppat NRIL01 (riprogrammaturi newronali ta’ limfoċiti inerenti) fil-preżenza tas-SARS-CoV-2, u b’hekk jikkontribwixxi biex inaqqas il-patoloġiji tal-kliewi bħala konsegwenza ta’ infezzjoni b’dan il-virus. (Maltese)
29 July 2022
0 references
Projektet fremlagt af LIMM Therapeutics har til formål at evaluere muligheden for at udvikle NRIL01 (neurnal reprogrammering af medfødte lymfocytter) i nærværelse af SARS-CoV-2 og dermed bidrage til at minimere nyrepatologier som følge af infektion med dette virus. (Danish)
29 July 2022
0 references
Proiectul prezentat de LIMM Therapeutics își propune să evalueze posibilitatea dezvoltării NRIL01 (reprogramatori neuronali ai limfocitelor înnăscute) în prezența SARS-CoV-2, contribuind astfel la minimizarea patologiilor renale ca urmare a infecției cu acest virus. (Romanian)
29 July 2022
0 references
Projektet som presenterades av LIMM Therapeutics syftar till att utvärdera möjligheten att utveckla NRIL01 (neurnal reprogrammerare av medfödda lymfocyter) i närvaro av SARS-CoV-2 och därigenom bidra till att minimera njurpatologier till följd av infektion med detta virus. (Swedish)
29 July 2022
0 references
Cantanhede
0 references
23 May 2023
0 references
Identifiers
CENTRO-01-02B7-FEDER-069917
0 references